After many years of intensive research, Prof Dr. Greilberger and Prof Dr. Herwig discovered the formula for the patented alphaH2+®, which protects against oxidative stress and positively favors the energy metabolism of the human organism.
The two founders of HG Pharma have been working on new biochemical forms of therapy for system regeneration for many years.
Confirmed by the 2019 Nobel Prize winners in the Physiology or Medicine category, cell researchers Kaelin, Ratcliffe and Semenza, who, among others, physiologically demonstrated the effects of oxidative stress on HIF-1 alpha.
Prof Dr Greilberger and Prof Dr Herwig are patent holders for several groundbreaking biomedical products, the effectiveness of which has been proven in numerous studies. Prof Dr Herwig has developed several procedures and tests that are now considered the “standard in medicine” and have been included in a wide variety of treatment guidelines from different medical societies.
The following research results and scientific achievements have also been made by Prof Dr Herwig patented: